SKAP1 and colonic neoplasm: Both reparixin and CXCL8‐neutralizing antibodies efficiently inhibited the NET‐enhancing effect of CM from SKAP1‐overexpressing colon cancer cells (Figure 5H,I; Figure S4C,D, Supporting Information).